Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Immuneering

Market Cap: US$505.9m

A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.

Lyell Immunopharma

Market Cap: US$244.4m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

NovaBay Pharmaceuticals

Market Cap: US$12.5m

Does not have significant operations.

Soligenix

Market Cap: US$6.9m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

Oramed Pharmaceuticals

Market Cap: US$98.4m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

Janux Therapeutics

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

Oculis Holding

Market Cap: US$915.9m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Harmony Biosciences Holdings

Market Cap: US$1.6b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Vertex Pharmaceuticals

Market Cap: US$97.9b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Bicara Therapeutics

Market Cap: US$583.8m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

Jasper Therapeutics

Market Cap: US$65.1m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.

AcuCort

Market Cap: €135.5m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Assertio Holdings

Market Cap: US$85.2m

A pharmaceutical company, provides various products to patients in the United States.

Aardvark Therapeutics

Market Cap: US$287.0m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

PlantArc Bio

Market Cap: ₪6.9m

Operates as an Ag-Bio company for the crop protection and yield enhancement.

argenx

Market Cap: €37.5b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Krystal Biotech

Market Cap: US$4.7b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Cantourage Group

Market Cap: €48.5m

Operates as a medical cannabis company in Europe.

Inhibikase Therapeutics

Market Cap: US$115.5m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Bright Minds Biosciences

Market Cap: CA$500.8m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Steep Hill

Market Cap: CA$1.1m

Does not have significant operations.

Clarity Pharmaceuticals

Market Cap: AU$1.4b

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.

Viking Therapeutics

Market Cap: US$2.9b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Zentiva

Market Cap: RON 3.2b

Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.

Zhejiang Xinguang Pharmaceutical

Market Cap: CN¥2.5b

Zhejiang Xinguang Pharmaceutical Co., Ltd.

NeoCore Technology

Market Cap: NT$1.3b

Designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices.

Renascience

Market Cap: JP¥22.9b

Engages in the development and commercialization of pharmaceuticals and medical devices in Japan.

Jiang Zhong PharmaceuticalLtd

Market Cap: CN¥13.7b

Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China.

Genetic Signatures

Market Cap: AU$61.3m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Yung Zip Chemical Ind

Market Cap: NT$889.8m

Yung Zip Chemical Ind. Co., Ltd., manufacturing, trading and sale of pharmaceuticals, pharmaceuticals, agricultural and industrial drugs, APIs, specialty chemicals and other related products internationally.

Sunmax Biotechnology

Market Cap: NT$22.0b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

Jiangxi Synergy Pharmaceutical

Market Cap: CN¥3.6b

Manufactures and sells APIs worldwide.

Amoy Diagnostics

Market Cap: CN¥8.7b

Engages in the development and commercialization of diagnostics product for oncology in China and internationally.

China Health Group

Market Cap: HK$190.1m

An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

Formosa Laboratories

Market Cap: NT$7.7b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Beijing Science Sun Pharmaceutical

Market Cap: CN¥5.4b

A biopharmaceutical company, engages in the research and development, production, and sales of injections in China.